Notably, resistance to cisplatin has been reported to be associated with the induction of Akt expression in colon cancer [34], and Akt/mTOR pathway inhibition reduced cisplatin resistance in ovarian and lung cancer cells [35,36]. Here, AKT1 is linked to lung cancer.